×

Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

  • US 9,844,655 B2
  • Filed: 02/12/2016
  • Issued: 12/19/2017
  • Est. Priority Date: 12/23/2010
  • Status: Active Grant
First Claim
Patent Images

1. A method for delivering a natalizumab dosage to a patient, the method comprising:

  • providing a solid natalizumab dosage shaped as a tissue penetrating member; and

    penetrating the tissue penetrating member into an intestinal wall after oral ingestion, wherein the natalizumab is released into the blood stream from the solid dosage natalizumab in the intestinal wall.

View all claims
  • 3 Assignments
Timeline View
Assignment View
    ×
    ×